Cancer is characterized by uncontrolled cell growth and division. Protein kinases regulate many of the pathways that control these processes. Mutations or dysregulation in protein kinases can lead to abnormal signaling that promotes tumorigenesis. For example, mutations in the BRAF kinase can lead to melanoma, while alterations in EGFR are associated with non-small cell lung cancer.
